摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-((-)N-cyclobutylmethylmorphinan-3-yl)-N-tert-butyloxycarbonyl-β-alanine

中文名称
——
中文别名
——
英文名称
1-((-)N-cyclobutylmethylmorphinan-3-yl)-N-tert-butyloxycarbonyl-β-alanine
英文别名
MCL 438;[(1R,9R,10R)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-yl] 3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate
1-((-)N-cyclobutylmethylmorphinan-3-yl)-N-tert-butyloxycarbonyl-β-alanine化学式
CAS
——
化学式
C29H42N2O4
mdl
——
分子量
482.663
InChiKey
ZUKHFLXNSQMMAV-ZLZBJJAKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.1
  • 重原子数:
    35
  • 可旋转键数:
    9
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.72
  • 拓扑面积:
    67.9
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    New Opioid Designed Multiple Ligand from Dmt-Tic and Morphinan Pharmacophores
    摘要:
    Here, we report the synthesis of a designed multi-pharmacophore ligand derived from the linkage of a delta selective peptide antagonist (Dmt-Tic) and a mu/kappa morphinan agonist butorphan (MCL 101) through a two methylene spacer. The new compound MCL 450 maintains the same characteristics as those the two reference compounds. MCL 450 represents a useful starting point for the synthesis of other multiple opioid ligands endowed with analgesic properties with low tolerance and dependence.
    DOI:
    10.1021/jm0605785
  • 作为产物:
    描述:
    Boc-beta-丙氨酸butorphan4-二甲氨基吡啶盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下, 以 二氯甲烷 为溶剂, 以50%的产率得到1-((-)N-cyclobutylmethylmorphinan-3-yl)-N-tert-butyloxycarbonyl-β-alanine
    参考文献:
    名称:
    New Opioid Designed Multiple Ligand from Dmt-Tic and Morphinan Pharmacophores
    摘要:
    Here, we report the synthesis of a designed multi-pharmacophore ligand derived from the linkage of a delta selective peptide antagonist (Dmt-Tic) and a mu/kappa morphinan agonist butorphan (MCL 101) through a two methylene spacer. The new compound MCL 450 maintains the same characteristics as those the two reference compounds. MCL 450 represents a useful starting point for the synthesis of other multiple opioid ligands endowed with analgesic properties with low tolerance and dependence.
    DOI:
    10.1021/jm0605785
点击查看最新优质反应信息

文献信息

  • New Opioid Designed Multiple Ligand from Dmt-Tic and Morphinan Pharmacophores
    作者:John L. Neumeyer、Xuemei Peng、Brian I. Knapp、Jean M. Bidlack、Lawrence H. Lazarus、Severo Salvadori、Claudio Trapella、Gianfranco Balboni
    DOI:10.1021/jm0605785
    日期:2006.9.1
    Here, we report the synthesis of a designed multi-pharmacophore ligand derived from the linkage of a delta selective peptide antagonist (Dmt-Tic) and a mu/kappa morphinan agonist butorphan (MCL 101) through a two methylene spacer. The new compound MCL 450 maintains the same characteristics as those the two reference compounds. MCL 450 represents a useful starting point for the synthesis of other multiple opioid ligands endowed with analgesic properties with low tolerance and dependence.
查看更多